Evidence map›Paper›PMID 38720974›Full record

ArticleRSC advances2024

CHN nanocomposites and nanocoating resist enamel white spot lesions by enhancing remineralization and antibacterial activity.

Lihui Wang, Shuqiang Niu, Shanshan Xu, Yanling Yu, Yuanping Hao

Abstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lihui WangSchool of Shandong Second Medical University Weifang 261053 Shandong China.
Shuqiang NiuQingdao Stomatological Hospital Affiliated to Qingdao University Qingdao 266001 Shandong China qdkqyyl@163.com yphao@qdu.edu.cn +86-0532- 82796465 +86-186-6195-0867 +86-166-2238-0102.
Shanshan XuQingdao Stomatological Hospital Affiliated to Qingdao University Qingdao 266001 Shandong China qdkqyyl@163.com yphao@qdu.edu.cn +86-0532- 82796465 +86-186-6195-0867 +86-166-2238-0102.
Yanling YuQingdao Stomatological Hospital Affiliated to Qingdao University Qingdao 266001 Shandong China qdkqyyl@163.com yphao@qdu.edu.cn +86-0532- 82796465 +86-186-6195-0867 +86-166-2238-0102.
Yuanping HaoQingdao Stomatological Hospital Affiliated to Qingdao University Qingdao 266001 Shandong China qdkqyyl@163.com yphao@qdu.edu.cn +86-0532- 82796465 +86-186-6195-0867 +86-166-2238-0102.ORCID https://orcid.org/0000-0003-2930-2697

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enamel white spot lesions (WSLs) are usually caused by the dissolution of minerals (mainly calcium and phosphate) on the tooth surface due to the acidic environment in the oral cavity. Without timely intervention, WSLs may lead to white spots or a sense of transparency on the tooth surface, and even the formation of dental caries (tooth decay) in severe cases. The key to preventing and treating WSLs is inhibiting the activity of acid-producing bacteria and promoting the remineralization of demineralized enamel. In this study, the network structure formed by sodium tripolyphosphate (TPP) cross-linked chitosan was used to stabilize calcium phosphate, and the multifunctional nanocomposite was constructed by integrating antibacterial components of traditional Chinese medicine, honokiol nanoparticles (HK-NPs) and sodium fluoride to achieve the purpose of resisting cariogenic bacteria and remineralizing with sustained release of calcium and phosphate ions. Notably, we enhanced the remineralization effect of nanocomposites with the help of functional nanocoatings inspired by the mussel biomimetic coating. The experimental results show that the synergistic remineralization effect of nanocomposite and nanocoating is better than that of a single strategy. This multi-prong treatment strategy provides the theoretical and experimental basis for the clinical prevention and treatment of WSLs.

Identifiers

PMID38720974
PMCPMC11077560

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.